• Kevin Hassett, asked about the U.S. government selling its Intel (NASDAQ:INTC) stake, said it has been 'reassuring to see the company turn around sharply.'
  • The comment signals confidence in Intel's recovery but is not an announcement of a sale decision, timetable, or price target.
  • Intel's operating results have improved markedly, yet its shares remain volatile and the government's position is still subject to debate over exit strategy.

A Reassuring Turnaround, Not a Sale Signal

Kevin Hassett's remark on CNBC that it has been "reassuring to see the company turn around sharply" offers a vote of confidence in Intel's recovery. But it stops short of any commitment to sell the government's stake. The headline contains no sale decision, no timetable, and no price target. Efforts to reach the White House for clarification were not immediately successful.

As of November 6, the distinction matters: Intel's business is improving, while its share price has been sharply volatile. The government's investment remains substantially above its original $8.9 billion cost, according to subsequent reporting—unrealized gains, not proceeds already received by taxpayers.

Operating Recovery Meets Market Setback

Intel's October 29 earnings showed third-quarter revenue of $16.5 billion, up 21% year over year, with data-center and AI revenue up 78%. Adjusted earnings per share came in at $0.52 versus $0.23 a year earlier. Operating cash flow was $5.1 billion.

But shares fell approximately 29% on October 30 after disappointing fourth-quarter guidance, erasing about $12 billion from the reported value of the government's position that day. Intel forecast fourth-quarter revenue of $15 billion–$16 billion and adjusted EPS of $0.25, below the roughly $17.1 billion and $0.43 analysts expected. That gap—not the backward-looking revenue growth—drove the negative response.

Government Stake: Structure and Dilution

The government's position originated in an August 22, 2025 agreement converting previously allocated support into equity: $8.9 billion, comprising $5.7 billion in unpaid CHIPS and Science Act grants and $3.2 billion from the Secure Enclave program. The agreed shares were 433.3 million at $20.47 each, initially equivalent to 9.9% ownership. A five-year warrant to purchase an additional 5% at $20 per share is exercisable only if Intel ceases to own at least 51% of its foundry business.

That initial 9.9% figure should not be treated as unchanged: subsequent share issuance diluted the stake to roughly 8.2%, according to October reporting. Intel's latest filing also notes that some government-related shares remain in escrow and are released as Secure Enclave work is performed and payments received.

The policy debate is whether taxpayers should receive equity upside when public money supports private companies, versus concerns about government stock-picking and conflicts of interest. Hassett previously described the investment as a possible "down payment" on a sovereign wealth fund and said further government equity transactions were possible. A November 6 commentary argued that Washington needs clearer investment objectives, oversight, and rules for deciding when to sell; that is an opinion, not an announced policy.

AI Tailwinds and PC Headwinds

AI infrastructure spending is increasing demand for server processors, but competition for memory and other components is raising PC costs and weakening demand in Intel's large client business. Intel expects PC weakness to continue at least through the first half of 2027. This explains the apparent contradiction: Intel can post exceptional server growth while still delivering a disappointing company-wide outlook.

Intel remains globally exposed. Its earnings disclosures identify U.S.–China trade tensions, export controls, tariffs, Taiwan-related tensions, and Middle East disruption as risks. Government backing does not eliminate those dependencies. A particularly immediate example is the October explosion at Intel's Israeli fabrication plant, which killed two workers, caused an extended shutdown, and was expected to reduce revenue by approximately $600 million across two quarters.

What to Watch

The main tests are fourth-quarter results, the pace of recovery from the Israeli plant shutdown, Xeon supply expansion, and the depth of the PC downturn. Intel's own guidance points to lower revenue and margins than in the third quarter. A government sale remains an unresolved possibility, not a verified development established by Hassett's remark.

Intel needs to convert its technology roadmap and public/private funding into reliable manufacturing execution, outside customers, and sustainable profits. Its foundry still lost $1.85 billion in the latest quarter, despite stronger segment revenue. Most reported foundry revenue is internal and should not be interpreted as equivalent external customer demand.

Expert assessments remain mixed. Morningstar (NASDAQ:MORN)'s November 6 analysis calls the shares modestly undervalued after the decline but retains a "Very High" uncertainty rating, citing server strength alongside PC weakness and turnaround risk. Other analysts remain unwilling to recommend buying without clearer capacity improvements.

The essential distinction for interpreting Hassett's remark is that government investment returns, Intel's operating recovery, and the strategic value of U.S. chip manufacturing are three different measures of success—and they need not move together.

Correction: An earlier version misstated the diluted size of the government's stake. It is roughly 8.2%, not 9.9%.